Minoxidil Tablets

DRUG2 trials

Sponsors

Industrial Farmacéutica Cantabria, S.A.

Conditions

Androgenetic AlopeciaFemale Pattern BaldnessHealthy

Phase 1

Bioavailability Clinical Trial of Oral Minoxidil 1 mg

CompletedNCT06015516

Industrial Farmacéutica Cantabria, S.A.Healthy

Start: 2024-02-09End: 2024-03-08Updated: 2024-08-21

Phase 3

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Active, not recruitingNCT05888922

Industrial Farmacéutica Cantabria, S.A.Androgenetic Alopecia, Female Pattern Baldness

Start: 2024-10-17End: 2026-11-16Target: 520Updated: 2026-09-16

Related Papers

Pharmacokinetics and Safety of 1 mg Oral Minoxidil Tablets in Healthy Female Volunteers: A Phase I Randomized Crossover Clinical Trial

JEADV Clinical Practice2026-09-15